Archive

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Contributors: External author(s) only

Subjects: COVID-19, Pandemics, Vaccinations